Objectives: Concussion refers to changes in neurological function due to biomechanical forces transmitted to the head. The APOE ε4 allele is associated with brain injury severity. The objective was to determine if APOE gene variants are associated with concussion history and severity in rugby players.
experience severe complications following concussion (e.g. fatal cerebral swelling or "second impact syndrome") 9 . The potential risk of debilitating concussion outcomes for youth athletes emphasise the importance to investigate the genetic role on concussion in youth athletes. Although there is limited research on the genetic contribution to concussion risk, genetic variants have been associated with concussion susceptibility 10, 11 and severity 12, 13 . Concussion severity can be determined from the clinical recovery decision which is based on symptom resolution and neurocognitive improvement 16, 17 .
A promoter polymorphism (rs405509, -219 G>T) within the apolipoprotein E gene (APOE), shown to alter APOE mRNA expression 14 , and two non-synonymous APOE polymorphisms (rs429358: T>C, p.Arg112Cys, rs7412: C>T, p.Arg158Cys), which result in one of four apo-E isoforms (E2, E3, E4, rare E3r) 15 , have previously been associated with both concussion susceptibility 10, 11 and concussion severity 12, 13 . APOE encodes for the apolipoprotein E (apo-E), a lipid-transporting glycoprotein. The rs405509 TT genotype was over-represented in individuals with a concussion history (odds ratio 2.80, 95% confidence interval: 1.10 -6.90) 10 and in addition, the APOE-ε4 allele was reported to be associated with concussion history in collegiate athletes (odds ratio 9.80, 95% confidence interval:
1.00 -96.55) 11 . Furthermore, the TT genotype was associated with severe outcomes from concussion (death, vegetative state or severe disability; odds ratio 0.37, 95% confidence interval: 0.13 -1.01) 12 while APOE-ε4 was associated with greater severity for chronic brain injury in boxers (P=0.040) 13 .
The role of APOE rs405509 T and ε4 alleles in increased risk for Alzheimer"s disease is welldocumented 18, 19 .
The findings for APOE rs405509 single nucleotide polymorphism (SNP) and the APOE-ε isoforms, as derived from the rs429358-rs7412 haplotype analyses, have, unfortunately, not been consistently replicated in the various independent studies 20-22 . However, the overall biological evidence from expression studies implicating the APOE rs405509 SNP (Ch. 19:44905579; 3105bp from rs429358, 3243bp from rs7412) in protein regulation 14 and APOE-ε2/ε3/ε4 isoforms (rs429358: Ch. professional with one or more concussion symptoms reported were categorized as a "diagnosed concussion"; whereas, concussions not diagnosed by a medical professional but with one or more symptoms reported were categorized as a "self-reported concussion". Symptoms were selected from the concussion consensus approved list in the Sports Concussion Assessment Tool version 3 (SCAT3), and included 14 physical (e.g. headaches), six cognitive (e.g. loss of consciousness) and four emotional (e.g. irritability) symptoms.
Individuals who (i) signed the informed consent (≥ 18 years old; N=271) or (ii) signed the assent (minor) and consent (parent/guardian) forms (< 18 years old; N=129) and (iii) also completed the information forms (N=400) were included in this study. Participants were excluded from this study based on (i) ancestry, only individuals who self-identified as white were included in this study (N=82 were excluded) because of population stratification effects, (ii) sporting activity (only rugby players were included; N=1 was excluded), and (iii) sex, only males were included (N=314) while three females were excluded. Furthermore, only individuals who sustained a rugby-related concussion were included (N=15 were excluded). Participants self-reporting meningitis (N=4), stroke (N=2) and seizures (N=3) were excluded. Finally, the known relatives of participants (N=2), were excluded.
After all exclusions, a total of 288 white, male rugby players (aged 12 -39 years old) were analysed; with 128 participants self-reporting no history of concussions (control group, CON) and 160 participants with previously diagnosed and self-reported concussions (all cases group, ALL; Supplementary Fig. S1 ). A subgroup, of the all cases group, was comprised only of the previously diagnosed concussed participants and separately analysed (clinically diagnosed subgroup, CLIN; N=139). All participants were analysed collectively and the junior group (N=121, 12 -18 year old high school rugby players) was also independently analysed, due to the vulnerability of youth athletes to adverse complications from concussion [7] [8] [9] , however, as a result of the small sample size in juniors, the exploratory analysis of the junior group was performed and included in the supplementary material ( Supplementary Tables S3). Participants completed details of their four most recent previous concussions (if applicable), and their sporting and medical histories ( Supplementary Table S4 ). Participation in sports was categorized into rugby (in isolation), non-rugby collision sports, non-rugby contact sports and non-contact sports. For rugby participation, participants self-reported the total number of years playing rugby. All participants donated a blood or buccal sample for genetic analysis. DNA was obtained and extracted from either a cheek swab as per the manufacturers" protocols 25 or a 5 ml venous blood sample as previously described 26 .
The selected APOE gene SNPs, rs405509 (-219 G>T) 14 , rs429358 (T>C), rs7412 (C>T) 15 , had a > 5% minor allele frequency in the white European population (NCBI, https://www.ncbi.nlm.nih.gov/). The C to T substitution at the first codon position, of the rs429358 and rs7412 SNPs, results in a protein change from arginine (CGC) to cysteine (TGC). The rs429358 (T3937C) and rs7412 (C4075T) haplotype was used to infer the APOE isoforms namely: C 3937 -C 4075 for ε4 allele, T 3937 -C 4075 for ε3, C 3937 -T 4075 for ε3r and T 3937 -T 4075 for ε2 ( Supplementary Fig. S2 ) 27 . The APOE polymorphisms were genotyped, at the Division of Exercise Science and Sports Medicine laboratory, using fluorescence-based TaqMan® real time polymerase chain reaction (PCR) assays and the StepOnePlus™ Real Time PCR machine as per the manufacturer"s protocol (Applied Biosystems, CA, USA). Briefly, the cycling conditions used were a holding stage at 95°C for 10 min, 55 cycles of 92°C for 15s and 60°C for 1 min. In a total of 10μl, 2x TaqMan® master mix reagent (Applied Biosystems, CA, USA), 0.25μl of target-specific TaqMan® assay (40x) and 1μl of DNA (6 -77 ng/µl) were used. Three repeat samples of known genotypes and three samples with no DNA were included as controls. An average genotype call rate of 95% (rs405509: 96%, rs429358: 93% and rs7412: 97%) was noted.
Sample size for this study was determined using QUANTO version 1.2.4 (http://biostats.usc.edu/software). Assuming minor allele frequencies from 0.1 to 0.8, the current study sample size of 160 cases is suitable to detect an allelic odds ratio of 2.0 (as per previous studies), at 80% statistical power and 5% significance level. All images and figures were designed using GraphPad Prism statistical software version 5.03 (GraphPad Software, San Diego, CA, USA).
Statistical analysis was performed using the R language and environment 28 . The Hardy-Weinberg equilibrium (HWE) probabilities and genotype frequency distribution differences between groups were determined using the genetics and SNPassoc packages 29 . Where appropriate and hypothesisdriven, the APOE rs405509 TT genotype was compared to the combined GG and GT genotype frequencies and GG was also compared to the combined TT and GT. Similarly, for the APOE (ε2/ε3/ε4) isoform with the ε4 allele compared against the ε3 and ε2 alleles. Allele frequency differences between groups were determined using Fisher"s exact test. The haplo.stats package was used to analyse the rs405509, rs429358 and rs7412 SNPs as an inferred haplotype, with the rs429358-rs7412 haplotype representing the APOE (ε2/ε3/ε4) isoform. When all participants were combined, all analyses were adjusted for age as a confounding covariate. In addition to the case-control analysis (i.e. concussion history), the genotype, allele and haplotype frequencies were compared between selfreported concussion symptom duration groups (< 1 week, ≥ 1 week). Symptom duration is used in the clinical decision to determine recovery, which in turn is a proxy for concussion severity 16, 17 .
Therefore, severity was inferred from symptom duration. When all participants were combined, participants self-reported concussions and symptom duration on average 2.5 ± 2.7 years (N=140) after the concussion occurred. A hypothesis-driven approach was adopted with all polymorphisms located on a single gene, of which rs405509 and rs7412 (D"=0.927, r 2 =0.278) and rs429358 and rs7412 (D"=0.995, r 2 =0.136) are in high linkage disequilibrium, and therefore correcting for multiple testing would be too conservative 30 . Statistical significance was set at P<0.05.
Results
The concussed case group (N=160) reported an average of 1.9 ± 1.0 previous concussions (45% sustained one concussion, 34.4% sustained two concussions, 8.8% sustained three concussions, 11.9% sustained four concussions). When all participants (N=188) were combined, the CON group (N=128) was significantly younger than ALL group (N=160) (P=0.008; CON: 19.2 ± 3.5 years old; ALL: 20.5 ± 4.4 years old) and CLIN subgroup (N=139) (P=0.015; CLIN: 20.4 ± 4.2 years old). Height, mass, body mass index (BMI), rugby exposure and non-rugby collision sport exposure were not significantly different between groups ( Supplementary Table S1 ).
No genotype association was observed for the APOE rs405509, rs429358 and rs7412 SNPs and the APOE-ε isoform (ε2, ε3 and ε4 were identified but ε3r was not) on participant characteristics (Supplementary Table S2 ).
The rs405509 genotype frequency distribution was not significantly different between the CON group and the ALL group or the CLIN subgroup (Table 1 ). In contrast to the a priori hypothesis, the TT genotype was significantly over-represented in the CON group compared to ALL group with 45% reduced concussion susceptibility (TT vs. GG + GT: age-adjusted P=0.043; CON: N=35, 29%, ALL:
N=28, 18%, odds ratio 0.55, 95% confidence interval: 0.31 -0.98). No significant rs429358 and rs7412 genotype frequency differences were observed between groups. The rs405509, rs429358 and rs7412 allele frequency distributions were also not significantly different between groups. All three SNPs (rs405509, rs429358 and rs7412) were in HWE for the control and case groups (P>0.05).
The allele frequency distribution of APOE (ε2/ε3/ε4) isoform was calculated using the inferred APOE rs429358-rs7412 haplotypes ( Supplementary Fig. S2 ). The APOE-ε isoform frequencies were not significantly different between the control and case groups (data not shown). Furthermore, the APOEε isoform distribution was in HWE in the control and case groups (P>0.05). The inferred APOE haplotypes (rs405509-ε2/ε3/ε4) were derived using the genotype data [rs405509 (G>T), rs429358 (T>C), rs7412 (C>T)]. In total, five inferred haplotypes, above a frequency of 4%, were identified (Fig. 1A) . The T-ε3 haplotype was significantly over-represented in the CON group Fig. 1A ). No significant differences for the APOE (ε2/ε3/ε4) allele frequencies were observed between groups (P>0.05; Fig. 1B ).
Of the total 160 concussed cases, 83% reported on their previous concussion symptom duration (65% reported symptoms persisting < 1 week, 35% reported symptoms persisting ≥ 1 week). Age, height, mass, BMI, rugby exposure and non-rugby collision sport exposure were not significantly different between the concussion symptom duration groups ( Supplementary Table S1 ).
No significant rs405509, rs429358 and rs7412 genotype frequency differences were noted between duration groups (Table 2 ). In contrast to the a priori hypothesis, no significant rs405509 genotype differences between groups were noted. No significant rs405509, rs429358 and rs7412 allele frequency differences were noted, except for the rs405509 in which the T allele was significantly over-represented in the < 1 week duration group (< 1 week: N=70, 50.7%) compared to the ≥ 1 week duration group (≥ 1 week: N=29, 36.3%; odds ratio 0.55, 95% confidence interval: 0.30 -1.01;
P=0.048). The APOE-ε isoform frequency distribution was not significantly different between duration groups (data not shown). In total, four inferred APOE haplotypes (rs405509-ε2/ε3/ε4), above a frequency of 4%, were identified for the duration groups. No significant differences were noted for the four inferred APOE haplotypes (rs405509-ε2/ε3/ε4) between the duration groups (data not shown).
Discussion
The aim of this exploratory study was to investigate the association between the APOE SNPs (rs405509, rs429358, and rs7412), concussion history and severity in rugby players. The main preliminary findings of the study noted for all participants collectively, included: (i) the rs405509 TT genotype was significantly associated with a 45% reduced risk of concussion susceptibility (odds ratio 0.55, 95% confidence interval: 0.31 -0.98), (ii) the novel association of the inferred APOE (rs405509-ε2/ε3/ε4) T-ε3 haplotype with reduced concussion risk while the G-ε3 haplotype was associated with increased concussion risk, (iii) no independent association was noted between APOE ε2/ε3/ε4 genotypes and concussion susceptibility, and (iv) the rs405509 TT genotype was significantly associated with reduced severity (< one week recovery) following a concussion. These preliminary findings collectively suggest that the APOE rs405509 T allele may be associated with reduced concussion susceptibility and the alternate G allele with an increased susceptibility.
The promoter rs405509 (-219 G>T) SNP is located in the transcriptional regulatory region of APOE and has been implicated in the regulation of APOE expression 14 . In particular, the T allele of rs405509 was shown to stimulate increased promoter activity and nuclear protein binding 14 , thereby increasing apo-E protein expression. The TT genotype has been linked with greater amyloid β protein deposition which is associated with Alzheimer"s disease pathology 31 . The odds ratio of 0.55 for TT genotype and reduced risk in this study is a similar effect size as previous studies with odds ratios varying from 0.37 to 2.80 10, 12 . The previous studies 11, 20 ,21 which did not replicate the rs405509 and concussion risk association were constrained by small sample sizes and inappropriate methods of statistical analysis for determining genotype distribution. The phenomenon of population stratification, which is accounted for in this study, highlights the importance of only comparing individuals of similar ancestry and may also explain the discrepancies in the findings of previous studies which did not account for this. Although the evidence implicating APOE rs405509 locus with the risk of concussion is conflicting, the evidence from the functional studies 14 still implicate this APOE promoter region in neurodegenerative diseases.
For all participants, the T allele was independently associated with rapid recovery ( Table 2) . Although it was interesting to note that the TT genotype was also associated with rapid recovery while GG genotype was associated with prolonged recovery in juniors, the wide confidence intervals and the small sample size constrained the confidence in these associations in juniors ( Supplementary Table   S3 ).
The APOE-ε4 allele plays a role in the pathological deposition of amyloid β protein 32 . A previous study has reported an association between the ε4 allele and increased concussion risk 11 . The extremely wide confidence interval and close to non-significant P-value (odds ratio 9.8, 95%
confidence interval: 1.00 -96.55, P=0.050), limits confidence in the significant association reported 11 . Furthermore, previous studies found no association between the ε4 allele and concussion risk 20,21 .
This study was unable to demonstrate an association between ε4 allelic polymorphism with concussion risk. The lack of associations in the current study and previous studies 20,21 could possibly be due to an insufficient sample size to detect the rare ε4 "risk" allele. It is evident that apo-E plays an important biological role within the brain and specifically its isoforms differentially modulate neurite growth, altering the cytoskeleton thereby playing a role in neuronal repair and maintenance 23 .
A seminal study implicated the ε4 allele in traumatic brain injury severity in boxers 13 . Conversely, no association was found between the ε4 allele and severity of mild traumatic brain injury in paediatrics 22 . Our current study did not find an association between ε4 allele and prolonged symptom duration in concussed individuals, a proxy for concussion severity. Previous studies which found significance for rs405509 and APOE-ε4 with concussion severity investigated traumatic and more severe head injuries compared to the concussions sustained in our cohort, in which no severe disability or debilitating outcome was reported.
This study"s genotype and allele frequency distributions were in HWE ( Table 1 ). The rs405509 (T=51%), rs429358 (C=15%) and rs7412 (T=10%) minor allele frequencies, within the CON group, are in alignment with NCBI frequencies for the white population (rs405509 T=49%, rs429358 C=15% and rs7412 T=8%, https://www.ncbi.nlm.nih.gov/projects/SNP/). This implies that the significant genotype associations found in this study are possibly not affected by evolutionary elements (e.g.
genetic drift) and population stratification but rather the concussion phenotype.
The T-ε3 and G-ε3 haplotypes were associated with concussion history thereby implicating the T allele in decreased susceptibility and the G allele in increased susceptibility. The T allele increases APOE promoter activity, increasing apo-E protein expression which could decrease amyloid β deposition, thereby decreasing or preventing the release of cytokines and reactive oxygen species and preventing neuronal apoptosis. Alternatively, the G allele decreases APOE promoter activity, decreasing apo-E protein expression which increases amyloid β deposition thereby eliciting the release of cytokines and reactive oxygen species leading to neuronal apoptosis. We propose that the T allele provides a neuroprotective response to a head knock protecting the brain against the development of concussion signs and symptoms. Additionally, this neuroprotective response could promote a favourable outcome and a rapid recovery following concussion. Whereas, the G allele promotes a neurodegenerative response following a head knock, provoking the concussion signs and symptoms. This neurodegenerative response could lead to a poor outcome and a prolonged recovery following concussion.
Although the results were preliminary, it was interesting to note an independent association betwee n rs405509 T allele and reduced concussion susceptibility was observed when only juniors were evaluated. The small sample size for juniors limits interpretation of this finding. The vulnerability of youth athletes to prolonged recovery and debilitating post-concussion complications 7-9 highlight the need for future studies to evaluate APOE genetic profiles and concussion aetiology in a larger cohort of youth athletes.
One of the limitations of this study is the inclusion of self-reported concussions and concussion symptom duration (an average of 2.5 ± 2.7 years recall after the concussion for all participants; 1.0 ± 1.3 years recall after the concussion for juniors), which can be influenced by potentially inaccurate participant recall. This can result in misreporting of concussion and symptom resolution. However, 87% (N=139) of the cases from all participants were diagnosed by a medical professional. Participants self-reporting ancestry could potentially result in inaccurate ancestry identification which multidimensional scaling tools (e.g. Plink) may have more accurately assigned. A reduced statistical power indicates an increased likelihood that the significant associations might be false positives (Type I error). This may be true for the symptom duration association, in juniors, with only 30% power detection ( Supplementary Table S3 ).
Conclusion
The observed associations for this APOE region and concussion aetiology could be a reflection of linkage disequilibrium with causal polymorphisms located elsewhere on APOE or closely-related genes. Therefore, future studies should explore this region or related regions to identify sequence motifs which may be directly related to concussion susceptibility. As well as, further studies in larger cohorts should be performed particularly for the association of APOE-ε isoform. The novel finding of this study was the inferred APOE rs405509-ε2/ε3/ε4 haplotypes modulating the risk of concussion which provides evidence to support the further elucidation of the APOE gene in concussion aetiology.
Practical Implications
 APOE rs405509 TT genotype may be associated with reduced concussion susceptibility.
 APOE-ε4 allele was not associated with concussion susceptibility.
 The TT genotype may influence symptom duration following a concussion. Recurring headache/migraine 9 11.9 (5) 8.3 (4) a Total number (N) of participants self-reporting a medical condition. Medical conditions for CON and ALL are displayed as percentages with the number of participants with non-missing data (N) in parentheses. b A broad term for self-reporting a learning disability, low learning level, attention deficit disorders or medication prescribed for learning disorders (e.g. Rittelin). c Self-reporting more than one medical condition
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Supplementary figure legends
Figure S1 Participant recruitment and eligibility
The number of participants included in the study (highlighted in boxes), are displayed as control and case groups, with the number (and reason) of excluded participants (not highlighted). The final total included and analyzed participants are grouped below the dotted lines with 128 control participants and 160 concussed case participants, with a subgroup of 139 diagnosed case participants.
*Participants of similar ancestry can only be compared because of population stratification and therefore only participants who had self-reported white ancestry, who presented the majority of the cohort, were analyzed in this study.
Figure S2 The APOE gene
The APOE gene is located at chromosome 19q3.2 consisting of four exons (black boxes), with the 5'- 
